BioJason Lettmann joined Morgenthaler in 2009 and is a Partner on the Life Science Team. Jason invests in biopharmaceutical and medical device companies and brings over 15 years of operating and venture experience in the life science sector. Jason currently serves on the Board of Directors of FIRE1, Promedior, Ra Pharmaceuticals, Relievant Medsystems, Second Genome, Spinewave and Vapotherm. Jason also recently establish ....
Education